Showing items 1–100
Anti-CD20 glycoantibodies and uses thereof
Grant US-11884739-B2
United States of America
Method for depleting malignant T-cells
Grant US-11885806-B2
United States of America
Nucleic acid molecules encoding chimeric antigen receptors targeting G-protein coupled…
Grant US-11866478-B2
United States of America
Chimeric antigen receptors targeting G-protein coupled receptor and uses thereof
Grant US-11820806-B2
United States of America
Human antibodies to human delta like ligand 4
Grant US-11820815-B2
United States of America
Bispecific antigen binding proteins
Grant US-11673945-B2
United States of America
Method for enhancing humoral immune response
Grant US-11649293-B2
United States of America
Preparations and methods for treating a GD2 positive cancer
Grant US-11597775-B2
United States of America
Tumor treatment method with an individualized peptide vaccine
Grant US-11564980-B2
United States of America
Nucleic acid molecules encoding anti-GPRC5D antibodies
Grant US-11566071-B2
United States of America
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased…
Grant US-11541047-B2
United States of America
T cell-redirected antigen-binding molecule for cells having immunosuppression function
Grant US-11505605-B2
United States of America
BCMA (CD269) specific chimeric antigen receptors for cancer immunotherapy
Grant US-11498971-B2
United States of America
Preparations and methods for treating a GD2 positive cancer
Grant US-11492412-B2
United States of America
Immunoactivating antigen-binding molecule
Grant US-11485790-B2
United States of America
Synergistic effect of anti-trop-2 antibody-drug conjugate in combination therapy for…
Grant US-11439620-B2
United States of America
Methods of depleting malignant T-cells
Grant US-11385233-B2
United States of America
Methods for modifying human antibodies by glycan engineering
Grant US-11377485-B2
United States of America
Colon and pancreas cancer specific antigens and antibodies
Grant US-11345733-B2
United States of America
Anti-TNF-alpha glycoantibodies and uses thereof
Grant US-11332523-B2
United States of America
Fucosidase from bacteroides and methods using the same
Grant US-11319567-B2
United States of America
Binding molecules specific for HER3 and uses thereof
Grant US-11305012-B2
United States of America
Methods for modifying human antibodies by glycan engineering
Grant US-11267870-B2
United States of America
Combining anti-HLA-DR or anti-Trop-2 antibodies with microtubule inhibitors, PARP…
Grant US-11253606-B2
United States of America
Efficacy of anti-Trop-2-SN-38 antibody drug conjugates for therapy of tumors relapsed/refra…
Grant US-11192955-B2
United States of America
Anti-neuropilin antigen-binding proteins and methods of use thereof
Grant US-11186644-B2
United States of America
CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen…
Grant US-11149076-B2
United States of America
Antibody-drug conjugates and uses thereof
Grant US-11116846-B2
United States of America
Combination of DR5 agonist and anti-PD-1 antagonist and methods of use
Grant US-11103579-B2
United States of America
Binding molecules specific for HER3 and uses thereof
Grant US-11091554-B2
United States of America
Cell injury inducing therapeutic drug for use in cancer therapy
Grant US-11072666-B2
United States of America
Cytotoxicity-inducing therapeutic agent
Grant US-11066483-B2
United States of America
Allogeneic tumor cell vaccine
Grant US-11058752-B2
United States of America
Antibody-drug conjugates and uses thereof
Grant US-11052156-B2
United States of America
Therapy for metastatic urothelial cancer with the antibody-drug conjugate, sacituzumab…
Grant US-11052081-B2
United States of America
HER2/neu-specific antibodies and methods of using same
Grant US-11028183-B2
United States of America
Preparations and methods for treating a GD2 positive cancer
Grant US-10995147-B2
United States of America
Combination therapy with anti-HLA-DR antibodies and kinase inhibitors in hematopoietic…
Grant US-10988539-B2
United States of America
Combination of ABCG2 inhibitors with sacituzumab govitecan (IMMU-132) overcomes…
Grant US-10954305-B2
United States of America
Bivalent, bispecific antibodies
Grant US-10927163-B2
United States of America
Treatment of cancer using humanized anti-CD19 chimeric antigen receptor
Grant US-10927184-B2
United States of America
Human iNKT cell activation using glycolipids with altered glycosyl groups
Grant US-10918714-B2
United States of America
Treatment of high Trop-2 expressing triple negative breast cancer (TNBC) with sacituzumab…
Grant US-10918734-B2
United States of America
Methods of treatments using chimeric antigen receptors targeting G-protein coupled…
Grant US-10906956-B2
United States of America
Stable heterodimeric antibody design with mutations in the Fc domain
Grant US-10875931-B2
United States of America
Antibody-drug conjugates and uses thereof
Grant US-10849986-B2
United States of America
Subcutaneous administration of antibody-drug conjugates for cancer therapy
Grant US-10799597-B2
United States of America
Nucleic acid encoding dual Fc antigen binding proteins
Grant US-10793621-B2
United States of America
Antibody-SN-38 immunoconjugates with a CL2A linker
Grant US-10751420-B2
United States of America
Therapy of small-cell lung cancer (SCLC) with a topoisomerase-I inhibiting antibody-drug…
Grant US-10744129-B2
United States of America
Anti-ErbB antibodies and methods of use thereof
Grant US-10745490-B2
United States of America
Anti-PD-1 antibodies and their uses
Grant US-10730953-B2
United States of America
Efficacy of anti-HLA-DR antibody drug conjugate IMMU-140 (hL243-CL2A-SN-38) in HLA-DR…
Grant US-10709701-B2
United States of America
Human monoclonal antibodies against CD25
Grant US-10703818-B2
United States of America
Combination of anti-KIR and anti-CTLA-4 antibodies to treat cancer
Grant US-10688180-B2
United States of America
Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular…
Grant US-10683345-B2
United States of America
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased…
Grant US-10682347-B2
United States of America
Antibody-drug conjugates and uses thereof
Grant US-10653793-B2
United States of America
Bispecific antigen binding proteins
Grant US-10640555-B2
United States of America
Chimeric antigen receptors targeting G-protein coupled receptor and uses thereof
Grant US-10633426-B2
United States of America
Anti-HER2 glycoantibodies and uses thereof
Grant US-10618973-B2
United States of America
Monovalent antigen binding proteins
Grant US-10611825-B2
United States of America
Antibodies, binding fragments, and methods of use
Grant US-10538592-B2
United States of America
Human iNKT cell activation using glycolipids
Grant US-10533034-B2
United States of America
Anti-HER3 antibodies and uses of same
Grant US-10526416-B2
United States of America
Monoclonal antibodies that specifically block biological activity of a tumor antigen
Grant US-10509037-B2
United States of America
Cancer markers and methods of use thereof
Grant US-10495645-B2
United States of America
Stable heterodimeric antibody design with mutations in the Fc domain
Grant US-10457742-B2
United States of America
Isolation, detection, diagnosis and/or characterization of circulating Trop-2-positive…
Grant US-10436788-B2
United States of America
Therapy for metastatic urothelial cancer with the antibody-drug conjugate, sacituzumab…
Grant US-10413539-B2
United States of America
Glycan conjugates and methods of use thereof
Grant US-10342858-B2
United States of America
Methods for modular synthesis of N-glycans and arrays thereof
Grant US-10336784-B2
United States of America
Glycan arrays for high throughput screening of viruses
Grant US-10338069-B2
United States of America
Multispecific domain exchanged common variable light chain antibodies
Grant US-10323099-B2
United States of America
Alkynyl sugar analogs for labeling and visualization of glycoconjugates in cells
Grant US-10317393-B2
United States of America
Glycan arrays on PTFE-like aluminum coated glass slides and related methods
Grant US-10274488-B2
United States of America
Biomarker profiles for predicting outcomes of cancer therapy with ERBB3 inhibitors and/or…
Grant US-10273304-B2
United States of America
Efficacy of anti-trop-2-SN-38 antibody drug conjugates for therapy of tumors relapsed/refra…
Grant US-10266605-B2
United States of America
Antibodies with immune effector activity and that internalize in folate receptor alpha-posi…
Grant US-10253106-B2
United States of America
Anti-KIR combination treatments and methods
Grant US-10253095-B2
United States of America
Cell-permeable probes for identification and imaging of sialidases
Grant US-10214765-B2
United States of America
Efficacy of anti-HLA-DR antiboddy drug conjugate IMMU-140 (hL243-CL2A-SN-38) in HLA-DR…
Grant US-10206918-B2
United States of America
Synergistic effect of anti-Trop-2 antibody-drug conjugate in combination therapy for…
Grant US-10195175-B2
United States of America
Biomarkers for predicting outcomes of cancer therapy with ErbB3 inhibitors
Grant US-10184006-B2
United States of America
Compositions and methods for treatment and detection of cancers
Grant US-10150818-B2
United States of America
Antibody-SN-38 immunoconjugates with a CL2A linker
Grant US-10143756-B2
United States of America
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased…
Grant US-10137196-B2
United States of America
Antibody-drug conjugates and uses thereof
Grant US-10130718-B2
United States of America
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased…
Grant US-10130626-B2
United States of America
Enhanced anti-influenza agents conjugated with anti-inflammatory activity
Grant US-10130714-B2
United States of America
HER2/neu-specific antibodies and methods of using same
Grant US-10131713-B2
United States of America
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
Grant US-10118969-B2
United States of America
Reactive labelling compounds and uses thereof
Grant US-10119972-B2
United States of America
Human iNKT cell activation using glycolipids with altered glycosyl groups
Grant US-10111951-B2
United States of America
RM2 antigens and use thereof
Grant US-10086054-B2
United States of America
Methods for modifying human antibodies by glycan engineering
Grant US-10087236-B2
United States of America
Combination therapy with anti-HLA-DR antibodies and kinase inhibitors in hematopoietic…
Grant US-10058621-B2
United States of America
Binding molecules specific for HER3 and uses thereof
Grant US-10040857-B2
United States of America
Antibody-SN-38 immunoconjugates with a CL2A linker
Grant US-10034950-B2
United States of America
Showing items 1–100